Forging a New Frontier: Antimicrobial Peptides andNanotechnology Converging to Conquer GastrointestinalPathogens

Descripción del Articulo

Gastrointestinal infections, which are caused primarily by pathogenicbacteria, remain a significant global health challenge. Their resilience isreinforced by various physical, biological, and biopharmaceutical barriers thatcomplicate conventional therapeutic strategies. This review delves into theint...

Descripción completa

Detalles Bibliográficos
Autores: Carnero Canales, Christian Shleider, Roque-Borda, Cesar Augusto, Marquez Cazorl, Jessica Ingrid, Marquez Cazorla, Renzo Marianito, Pinto Apaza, Uner Josseph, Vanderson de Jesus Silva, Duran Gleriani Primo, Laura Maria, Martínez-Morales, Maura Jennifer, Sábio, Rafael Miguel, A. Santos, Hélder, Rogério Pavan, Fernando
Formato: artículo
Fecha de Publicación:2025
Institución:Universidad Autónoma del Perú
Repositorio:AUTONOMA-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.autonoma.edu.pe:20.500.13067/3859
Enlace del recurso:https://hdl.handle.net/20.500.13067/3859
https://doi.org/10.1002/smll.202501431
Nivel de acceso:acceso abierto
Materia:Gastrointestinal infections
Nanotechnology
Antimicrobial peptides (AMPs)
Antibiotic resistance
https://purl.org/pe-repo/ocde/ford#3.01.05
Descripción
Sumario:Gastrointestinal infections, which are caused primarily by pathogenicbacteria, remain a significant global health challenge. Their resilience isreinforced by various physical, biological, and biopharmaceutical barriers thatcomplicate conventional therapeutic strategies. This review delves into theintricate landscape of managing these infections, addressing microbiotaimbalances, the emergence of multidrug-resistant strains, and the impact ofdysbiosis and antibiotic overuse. Faced with these challenges, traditionaltherapies often fail, which is hindered by low bioavailability, prolongedregimens, and a growing risk of resistance. In this context, nanotechnologyapplied to antimicrobial peptides (AMPs) has emerged as a promisingsolution to enhance their stability and targeted delivery. Through a criticalapproach, diverse nanocarriers and their efficacy against intestinal pathogensare evaluated both in vitro and in vivo. This review advocates for intensifiedresearch on the encapsulation and functionalization of AMPs, envisioningtheir potential to redefine the control of intestinal infections on a global scale.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).